SCHEMBL22601129

SCHEMBL22601129

Cc1ccc(S(=O)(=O)NC(=O)c2cc3ccc(N(C)C)cc3o2)c(-c2ccccc2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.48
ALDH1A1 P00352 3/20 0.48
HPGD P15428 3/20 0.48
POLB P06746 2/20 0.48
MEN1 O00255 2/20 0.48
KDM4E B2RXH2 2/20 0.48
GAA P10253 1/20 0.48
LMNA P02545 3/20 0.41
SLC16A3 O15427 1/20 0.39
NPC1 O15118 6/20 0.39
RAB9A P51151 6/20 0.39
MAPT P10636 3/20 0.39
THRB P10828 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
PTGER4 P35408 2/20 0.38
TSHR P16473 3/20 0.38
TP53 P04637 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22601140 0.90 SLC16A3 (0.42) KMT2AALDH1A1HPGDPOLBMEN1
SCHEMBL22587804 0.88 KDM4E (0.44) KMT2AALDH1A1HPGDPOLBMEN1
SCHEMBL24313791 0.85 KDM4E (0.51) KMT2AALDH1A1HPGDPOLBMEN1
SCHEMBL31723074 0.85 KDM4E (0.51) KMT2AALDH1A1HPGDPOLBMEN1
SCHEMBL22600971 0.83 RAB9A (0.42) KMT2AALDH1A1HPGDPOLBMEN1
SCHEMBL22587970 0.83 KMT2A (0.43) KMT2APTGER4PGR
SCHEMBL22587719 0.83 SLC16A3 (0.41) KMT2AALDH1A1HPGDPOLBMEN1
SCHEMBL22588229 0.83 RAB9A (0.47) KMT2AALDH1A1HPGDPOLBMEN1
SCHEMBL22588241 0.82 KDM4E (0.44) KMT2AALDH1A1HPGDPOLBMEN1
SCHEMBL22588194 0.82 PTGER4 (0.39) KMT2AALDH1A1HPGDPOLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3959202-B1 ACYL SULFONAMIDES FOR TREATING CANCER BAYER AG (DE) 2023-08-16 EP claimed
EP-3959202-B1 ACYL SULFONAMIDES FOR TREATING CANCER BAYER AG (DE) 2023-08-16 EP disclosed
WO-2020216701-A1 ACYL SULFONAMIDES FOR TREATING CANCER BAYER AKTIENGESELLSCHAFT (DE) 2020-10-29 WO disclosed